ACM
LLY icon

Adalta Capital Management’s Eli Lilly LLY Stock Holding History

Adalta Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$915K Sell
763
-246
-24% -$251K 0.4% 44
2026
Q1 		$928K Buy
1,009
+183
+22% +$186K 0.44% 42
2025
Q4 		$888K Buy
826
+123
+17% +$118K 0.4% 40
2025
Q3 		$536K Buy
703
+198
+39% +$147K 0.24% 55
2025
Q2 		$394K Sell
505
-5
-1% -$3.88K 0.2% 57
2025
Q1 		$421K Sell
510
-275
-35% -$229K 0.22% 56
2024
Q4 		$606K Hold
785
– – 0.32% 45
2024
Q3 		$695K Sell
785
-600
-43% -$539K 0.36% 45
2024
Q2 		$1.25M Buy
1,385
+200
+17% +$160K 0.68% 30
2024
Q1 		$922K Buy
1,185
+175
+17% +$125K 0.51% 36
2023
Q4 		$589K Buy
1,010
+365
+57% +$213K 0.36% 45
2023
Q3 		$346K Buy
645
+160
+33% +$82.4K 0.24% 55
2023
Q2 		$227K Buy
+485
New +$203K 0.15% 58

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adalta Capital Management's LLY Position: Q2 2026 in Review

Adalta Capital Management reduced its Eli Lilly (LLY) stake by 24% in Q2 2026, selling an estimated $251K and leaving 763 shares worth $915K. The position accounts for 0.4% of the portfolio, ranked #44.

Adalta Capital Management first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.25M in Q2 2024. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Adalta Capital Management held 763 shares of Eli Lilly worth $915K as of Q2 2026.
  • Adalta Capital Management sold 246 Eli Lilly shares in Q2 2026, an estimated $251K.
  • Eli Lilly made up 0.4% of Adalta Capital Management's portfolio in Q2 2026, its #44 holding.
  • Adalta Capital Management first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • Adalta Capital Management's Eli Lilly position peaked at $1.25M in Q2 2024.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Adalta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.